1

Martha Rosenberg – They’ve nominated WHO to head the FDA?

FDA nominee thinks being a Pharma consultant is a “very good thing” Imagine a doctor who “served as a director, officer, partner, employee, advisor, consultant or trustee for Genentech” and reports 23 financial links to drug companies including stock ownership being FDA commissioner? A doctor who defends Merck’s Vioxx behavior which cost thousands of lives and said “many of us …

1

Paul D. Thacker and Charles Seife – The Fight Over Transparency: Round Two

The backlash against transparency is now underway. The battles being waged are likely to leave their mark over how to perform — and how to interpret — the medical and scientific literature for many years to come. In the past two decades, it seemed like much of the debate over financial conflicts of interest had quieted. In the wake of …